Background/Aims: C reactive protein (CRP) levels are elevated in many diseases, including malignant tumors and cardiovascular disorders. In this study, the protein interaction network for CRP was evaluated to determine the importance of CRP and its interacting proteins in the molecular pathogenesis of hepatocellular carcinoma (HCC). Methods: Isobaric tags for relative and absolute quantitation (iTRAQ) and mass spectrometry were used to identify CRP interacting proteins in SMMC7721 cells. Moreover, Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) were used to evaluate enriched genes and pathways for differentially expressed genes using DAVID and WebGestalt. Co-immunoprecipitation and western blot analyses were employed to assess interactions between CRP and KRT8, ANXA2, ENO2, and HSP90B1. Results: In total, 52 proteins that interact with CRP were identified. A GO analysis suggested that most of the interacting proteins were involved in CRP complexes and regulated metabolic processes. A KEGG pathway analysis suggested that most CRPinteracting proteins contribute to the TRAIL signaling pathway, Class I PI3K/Akt signaling pathway, plasma membrane estrogen receptor signaling, Nectin adhesion pathway, and S1P1 pathway. Immunoprecipitation and western blot analyses revealed interactions between CRP and KRT8, ANXA2, ENO2, and HSP90B1. Conclusions: iTRAQ based proteomic profiling revealed the network of CRP interacting proteins. This network may activate the PI3K/Akt signaling pathway, thereby contributing to the pathogenesis of HCC.
Introduction
Hepatocellular carcinoma (HCC) is the most common primary malignant cancer affecting the liver. It is the fifth and seventh most common type of cancer affecting men and women, respectively, and is categorized as the second most common cause of cancer deaths among men and sixth most common cause of cancer deaths among women [1] [2] [3] . HCC has several known risk factors, including chronic hepatitis B virus and hepatitis C virus infections, liver cirrhosis, and several metabolic diseases [4] [5] [6] . Liver injury induced by these risk factors produces a progressive inflammatory milieu that results in a cycle of necrosis and regeneration and the development of chromosomal instability [7] . Genetic, proteomic, and epigenetic alterations that progressively accumulate in a background of increased reactive oxygen species, inflammatory cytokines, and fibrosis likely lead to the initiation of HCC [8] . The initiation and progression of HCC occur by multiple steps, but the precise molecular events that underlie HCC formation remain only partially understood.
Since the quantitative potential of proteomics was initially demonstrated, efforts have been made to develop and improve quantitative methods (e.g., ICAT [9] , iTRAQ [10, 11] , SILAC [12, 13] , and label free methods [14] ). These endeavors have focused primarily on obtaining high throughput quantitative information about the abundance of proteins at the scale of biological systems [6, 15, 16] . Since biological activity is executed directly by proteins, proteomic analyses of diseases or stages of diseases may shed light on the etiopathogenesis and deepen our understanding of these diseases, and may provide a basis for the development of improved treatment strategies. The iTRAQ method is considered a particularly powerful tool, since it can facilitate the simultaneous analysis of up to eight samples in a single experiment. Several features of iTRAQ, such as its high through-put ability, wide range of separation, high accuracy, and repeatability, have led to its widespread use in proteomics.
C reactive protein (CRP), the first acute phase protein described, is an ancient and highly conserved member of the pentraxin family; it has five identical subunits forming a planar ring that confers very high stability to the protein [17] . It is mainly synthesized by hepatocytes in response to various inflammatory stimuli [18] . The risk of cancer is increased when prediagnostic CRP levels are high [19] . Our previous results suggest a close relationship between CRP and HCC, and CRP levels are highly correlated with the extent of liver cancer invasion and migration [20] . Despite extensive clinical evidence for a role of CRP in the pathogenesis of HCC, an underlying molecular mechanism has not yet been identified.
With the development of proteomics, increasing studies have indicated that molecular functions and biological processes in cells are coordinated by protein complexes or protein networks, and protein-protein interactions have been a focus of cancer research. Co-immunoprecipitation (Co-IP) combined with mass spectrometry (MS) has become the method of choice for identifying protein-protein interactions [21, 22] . The identification of interacting proteins is an important way to understand the functions of CRP. Based on our previous study, we screened CRP interacting proteins a using a targeted proteomics approach (Co-IP coupled with iTRAQ based MS) to clarify the CRP related network and its role in the molecular pathogenesis of HCC.
Materials and Methods

Reagents and antibodies
Eight plex iTRAQ Reagent Kits were acquired from Applied Biosystems (Foster City, CA). Monoclonal antibodies against human CRP were obtained from HyTest (Finland, Turku), and the anti-Cytokeratin 8, antiAnnexin A2, anti-ENO2, and anti-HSP90B1 antibodies were purchased from Abcam (Cambridge, MA). CRPspecific Stealth Select RNAi™ small interfering RNA (siRNA) (NM_000567), Stealth RNAi™ Negative Control siRNA, and Lipofectamine Max transfection reagent were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Small interfering RNAs against human ENO2 (ID121346, ID 121348) and HSP90B1 (ID119655, ID 119656) were purchased from Invitrogen (Grand Island, NY). IP lysis buffer was purchased from Beyotime (Shanghai, China). Protein A/G agarose beads were obtained from GE Healthcare (Little Chalfont, UK).
Cell culture
Human liver cell lines SMMC7721 and Huh7 were cultured in high glucose DMEM containing 10% fetal bovine serum and 1% penicillin-streptomycin solution. They were maintained at 37°C in a humidified chamber with an atmosphere of 5% CO 2 until use.
CRP siRNA transfection, co-immunoprecipitation, and iTRAQ labeling SMMC7721 cells were transfected with 100 nM CRP-specific siRNA or a negative siRNA using Lipofectamine Max. CRP-specific siRNA effectively silenced CRP expression (Fig. 1A) . SMMC7721 cells were then trypsinized and lysed in 1 ml of lysis buffer on ice for 20 min after 48 h. Cell lysates were centrifuged for 30 min at 13, 000 rpm and 4°C. One milligram of the lysate (1 µg/µl) was mixed with 2 µg of CRP antibodies overnight at 4°C. Protein G beads were added to the immune complexes and incubated for 2 h under gentle agitation at 4°C. The beads were pelleted and washed three times with lysis buffer. Bound proteins were eluted in sodium dodecyl sulfate (SDS) sample buffer, subjected to SDS-polyacrylamide gel electrophoresis (PAGE), and analyzed by immunoblotting. The eluted protein (300 µg) was precipitated from each pooled group, dissolved in dissolution buffer, denatured, cysteine blocked, digested with 2 µg of sequencing grade modified trypsin, and labeled using iTRAQ reagents (Control siRNA, 118 and 121 tag; CRP siRNA 113 and 119 tag) provided with the iTRAQ Kit. Peptides from each sample set were mixed prior to subsequent analyses.
Mass spectrometry
Labeled peptides were fractionated and purified by immobilized-pH-gradient isoelectric focusing, as previously described [23, 24] . Purified peptide fractions were reconstituted in solvent A (water/ACN [98:2 v/v] with 0.1% formic acid) and separated using a C18-PepMap column (Thermo Fisher Scientific, Beijing, China) with a solvent gradient of 2-100% Buffer B (0.1% formic acid and 98% acetonitrile) in Buffer A at a flow rate of 0.3 µl/min. The peptides were electrosprayed using a nanoelectrospray ionization source at an ion spray voltage of 2300 eV and analyzed by a NanoLC-ESI-Triple TOF 5600 system (AB Sciex, Framingham, MA). The mass spectrometer was set to positive ion mode at a mass range of 300-1800 m/z. The two most intensely charged peptides above 20 counts were selected for MS/MS at a dynamic exclusion of 30 s [25] . Data were processed using ProteinPilot v2.0 (AB Sciex) and compared with the International Protein Index Human database v3.77. Cysteine modified by methane thiosulfate was specified as a fixed modification. Protein identification was based on a threshold protein score of >1.3. For quantitation, at least two unique peptides with 95% confidence and a P-value less than 0.05 were required. 
Bioinformatic analysis
The differentially expressed proteins and differently expressed genes (DEGs) between the control siRNA group and CRP siRNA group were identified using ProteinPilot TM . For protein identification, a confidence limit of 95% and a false discovery rate of 5% were used, and an additional threshold of less than 1.3 was applied to all iTRAQ ratios to minimize false positives for the determination of upregulated proteins. The significant gene ontology (GO) biological process terms and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways for the identified DEGs were evaluated using the Database for Annotation, Visualization, and Integrated Discovery (DAVID) and the WEB-based GEne SeT AnaLysis Toolkit (WebGestalt).
Western blotting
Western blot analyses were performed to validate the proteomic results using randomly chosen CRP-interacting proteins. SMMC7721 and Huh7 cell protein samples were collected in lysis buffer. Then, 1 mg of lysate (1 µg/µl) was mixed with 2 µg of CRP antibodies overnight at 4°C and 20 µl of Protein G beads for 2 h under gentle agitation at 4°C, and bound proteins were eluted in an equal volume of SDS sample buffer. Equal volumes of diluted samples were separated by SDS-PAGE and transferred onto polyvinylidene fluoride membranes. Membranes were blocked in 5% skim milk in Tris-buffered saline with Tween20, and incubated with primary antibodies against KRT8, ANXA2, ENO2, and HSP90B1. The membranes were then incubated with the horseradish peroxidase conjugated secondary antibody at room temperature. Finally, membranes were visualized using an electrochemiluminescence detection instrument (Bio-Rad Laboratories, Hercules, CA).
Confocal Microscopy SMMC7721 and Huh7 cells at a density of 1 × 10 5 cells per confocal culture dish were cultured with DMEM supplemented with 10% fetal bovine serum for 24 h. Then, cells were fixed with 10% (vol/vol) paraformaldehyde, perforated with 0.1% (vol/vol) Triton X-100, and blocked with 10% (vol/vol) normal goat serum in phosphate-buffered saline with Tween-20. Cells were incubated for 18 h in anti-CRP, anti-ENO2, and anti-HSP90B1 primary antibodies and were subsequently incubated in the appropriate speciesspecific Alexa fluorescent dye-conjugated secondary antibodies (Invitrogen) for 90 min at 37°C. The immunostained cells were viewed by confocal microscopy (Nikon, Melville, NY).
ENO2 and HSP90B1 siRNA transfection ENO2 or HSP90B1 siRNA was used for transfection into SMMC7721 and Huh7 cells according to protocols provided by Invitrogen. CRP expression was monitored by western blotting. [20] . In total, 52 unique proteins were successfully identified (fold change > 1.3 and p < 0.05) in the control siRNA group compared with the CRP siRNA group (Table 1) . A hierarchical clustering heat map of the differentially expressed proteins is shown in Fig. 1C .
GO term enrichment analysis of CRP interacting proteins
The results of the GO term enrichment analysis varied depending on GO classification and expression changes of DEGs. In total, 52 DEGs were uploaded to the online software DAVID and WebGestalt to identify overrepresented GO categories for an enrichment analysis. As shown in Fig. 2 , the enriched biological process terms (BP, Fig 2A) were primarily metabolic process (34, 66.7%), cellular component organization (31, 60.7%), biological regulation (28, 54.9%), response to stimulus (27, 52 .9%), and localization (25, 49.0%). The enriched molecular function terms (MF, Fig 2B) were mainly protein binding (36, 70 .5%), ion binding (22, 43 .1%), structural molecule activity (16, 31.3%), nucleotide binding (15, 29.4%), and hydrolase activity (10, 19.6%) . In an analysis of cellular components (CC, Fig 2C) , proteins were primarily enriched for the terms macromolecular complex (32, 62.7%), cytosol (29, 56 .8%), membrane (22, 43 .1%), cytoskeleton (20, 39 .2%), and membrane-enclosed lumen (17, 33.3%).
KEGG pathway enrichment analysis
Using the KEGG pathway database, the CRP interactome was classified into 65 pathways, the top 20 of which are shown in Fig. 3 . The TRAIL signaling pathway was the top 
pathway, followed by the Class I PI3K/Akt signaling pathway, plasma membrane estrogen receptor signaling, Nectin adhesion pathway, and S1P1 pathway. The KEGG maps related to the Class I PI3K/Akt signaling pathway suggest a fairly complicated molecular mechanism underlying HCC, as shown in Fig. 4 .
Disease enrichment analysis of the CRP interactome
Based on a disease enrichment analysis, CRP and CRP interacting proteins were primarily involved in skin diseases, cardiovascular diseases, metabolic diseases, and carcinoma (data not shown). Fig. 5 shows several diseases in liver, metabolic diseases, neoplasms, and syndromes associated with these proteins.
Protein verification by western blotting and immunofluorescence
Our proteomics analysis revealed many interesting protein interactions for CRP. To determine the reliability of the iTRAQ results, we selected several protein candidates and confirmed their expression by Co-IP and western blotting. As expected, KRT8, ANXA2, ENO2, and HSP90B1 were captured when CRP was used as the bait protein (Fig. 6 A) . To further explore in vivo interactions, subcellular localization studies were performed. Confocal microscopy of cells co-labeled with antibodies recognizing CRP and ENO2 or HSP90B1 revealed co-localization within the HCC cells SMMC7721 and Huh7 (Fig 6B) . The percentage of CRP co-localizing with either ENO2 or HSP90B1 was analyzed and quantified using ImageJ (co-localization was identified by yellow areas, and scatter plots and Pearson correlation coefficients indicated the relationship between CRP and ENO2 or HSP90B1). Co-localization of CRP with proteins identified by MS using immunofluorescence. Hepatoma cells SMMC7721 and Huh7 were stained with an anti-CRP antibody and an anti-ENO2 or anti-HSP90B1 antibody, followed by incubation with FITC-conjugated donkey anti-rat IgG (for ENO2, HSP90B1) or PE-conjugated goat anti-mouse IgG (for CRP) and visualization using a confocal microscope. (Co-localization was identified by the yellow areas, and scatter plots and Pearson correlation coefficients indicated the relationship between CRP and ENO2 or HSP90B1). Based on a disease enrichment analysis, CRP and CRP-interacting proteins were primarily involved in skin diseases, cardiovascular diseases, metabolic diseases, and carcinoma (data not shown). Fig. 5 shows several diseases in liver, metabolic diseases, neoplasms, and syndromes related to these proteins. These results indicated that some key proteins may directly regulate diseases. High levels of these proteins in circulation are closely related to the occurrence, progression, and prognosis of diseases.
Based on the results of the GO and KEGG analyses, we selected four key protein candidates that mediate tumor progression or play an important role in related signaling pathways. We discuss these key proteins in the following text.
ENO2 (Gamma-enolase) is an intracellular enzyme that catalyzes the dehydration of 2-phospho-d-glycerate to phosphoenolpyruvate in the catabolic direction of the glycolytic pathway. The glycolytic pathway and its enzymes are among the most highly conserved and important metabolic networks and have pleiotropic effects in physiological and pathological processes, including cancer. For instance, ENO2 may bind to actin and tubulin, mediate invasiveness and microtubule motility in tumor cells, and increase the phosphoprotein levels of the PI3K/Akt signaling pathways [45] . HSP90B1 is an endoplasmic reticulum protein; it chaperones and aids in the folding of client proteins, including Toll-like receptors, Wnt coreceptor LRP6, insulin-like growth factors, and integrin [46] . Hepatocytes are highly metabolic cells with active protein synthesis and secretory machinery, including coagulation factors, complement proteins, C reactive protein, and many others involved in ER maintenance and efficient stress responses. A previous study suggested that gp96 is an oncogenic chaperone in hepatocyte carcinogenesis and a promising therapeutic target for liver cancer [46] . We found that ENO2 and HSP90B1 were significantly down-regulated when CRP was silenced, indicating that the depletion of CRP inhibited ENO2 and HSP90B1 expression in HCC cells. Additionally, when ENO2 or HSP90B1 was inhibited, the level of CRP also decreased. Furthermore, CRP co-precipitated and was co-located with ENO2 and HSP90B1 in HCC cells, indicating that CRP may mediate tumor progression, ER stress, and the activation of tumor-related signaling pathways, including PI3K/Akt, by binding to ENO2 or HSP90B1.
Finally, KRT8 and ANXA2 interacted with CRP and exhibited decreased expression in response to CRP silencing. According to previous studies, high KRT8 expression promotes tumor progression and metastasis by regulating epithelial-mesenchymal-transition and cellmatrix adhesion [47] ; several annexin A2-interacting proteins mediate tumor progression via the phosphorylation and translocation of annexin A2 to the cell surface [48] . Considering the functions of these proteins, it is reasonable to predict that CRP is involved in the molecular pathogenesis of HCC by interacting with these proteins.
Conclusion
In this study, the CRP-interacting protein network was characterized by Co-IP and iTRAQ based proteomic profiling. The CRP-interacting protein network may activate HCC-related signaling pathways to contribute to the pathogenesis of HCC. The results of this study should be verified in future research.
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